Time: February 5, 2014 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone Website or Map: http://www.readytalk.com/ Phone: 866.740.1260 -- Access code: 9449985 Event Type: webinar
Organized By: PPMD Latest Activity: Nov 14, 2014
Export to Outlook or iCal (.ics)
On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT DMD).
Join PPMD Community
Hi Steven - We'll have the recording up early next week.
Hi, is there a recording of the webinar? If not, anyone got any feedback? Thanks.
Welcome toPPMD Community
Sign Upor Sign In
Or sign in with:
Need help using this community site? Visit Ning's Help Page.
April 21, 2018 all day – Charles F. Patton Middle School
© 2018 Created by PPMD.
Report an Issue |
Terms of Service
Please check your browser settings or contact your system administrator.